Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |